Forian Correlations
FORA Stock | USD 2.04 0.03 1.45% |
The current 90-days correlation between Forian Inc and Progyny is -0.09 (i.e., Good diversification). The correlation of Forian is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Forian Correlation With Market
Significant diversification
The correlation between Forian Inc and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Forian Inc and DJI in the same portfolio, assuming nothing else is changed.
Forian |
Moving together with Forian Stock
0.73 | ENOV | Enovis Corp | PairCorr |
0.85 | AMN | AMN Healthcare Services | PairCorr |
0.77 | ACON | Aclarion | PairCorr |
0.76 | VCNX | Vaccinex | PairCorr |
0.82 | CGC | Canopy Growth Corp Upward Rally | PairCorr |
0.85 | INAB | In8bio Inc | PairCorr |
0.8 | KALA | Kala Pharmaceuticals | PairCorr |
Moving against Forian Stock
0.8 | DOCS | Doximity | PairCorr |
0.71 | MMSI | Merit Medical Systems Earnings Call This Week | PairCorr |
0.68 | VEEV | Veeva Systems Class | PairCorr |
0.6 | DOMH | Dominari Holdings | PairCorr |
0.49 | CVS | CVS Health Corp | PairCorr |
0.47 | A | Agilent Technologies Earnings Call This Week | PairCorr |
0.45 | TFX | Teleflex Incorporated | PairCorr |
0.9 | GILD | Gilead Sciences | PairCorr |
0.82 | EXAS | EXACT Sciences | PairCorr |
0.8 | BMY | Bristol Myers Squibb | PairCorr |
0.76 | TIL | Instil Bio | PairCorr |
0.66 | INBX | Inhibrx Symbol Change | PairCorr |
0.61 | EXEL | Exelixis Earnings Call This Week | PairCorr |
0.42 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.84 | ALRN | Aileron Therapeutics | PairCorr |
0.81 | PAHC | Phibro Animal Health | PairCorr |
0.8 | MNOV | MediciNova | PairCorr |
0.63 | NGNE | Neurogene Symbol Change | PairCorr |
0.38 | ABBV | AbbVie Inc Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Forian Stock performing well and Forian Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Forian's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PGNY | 2.66 | (0.73) | 0.00 | (0.71) | 0.00 | 3.71 | 38.70 | |||
TDOC | 2.84 | (0.12) | (0.02) | 0.01 | 3.66 | 5.86 | 17.13 | |||
GDRX | 2.16 | (0.45) | 0.00 | (0.74) | 0.00 | 3.91 | 24.52 | |||
TXG | 3.46 | (0.41) | 0.00 | (0.05) | 0.00 | 6.34 | 39.27 | |||
SDGR | 2.35 | (0.49) | 0.00 | (0.12) | 0.00 | 5.68 | 12.65 | |||
DOCS | 1.88 | 0.60 | 0.30 | 0.73 | 1.32 | 2.88 | 42.30 | |||
AMWL | 3.75 | 0.30 | 0.06 | 0.32 | 4.74 | 7.24 | 53.68 | |||
GEHC | 1.05 | 0.06 | 0.05 | 0.15 | 1.09 | 2.36 | 6.28 | |||
CERT | 2.12 | (0.68) | 0.00 | (0.36) | 0.00 | 3.48 | 15.46 | |||
HQY | 1.72 | 0.08 | 0.06 | 0.13 | 2.17 | 3.41 | 12.74 |
Forian Corporate Management
Edward Spaniel | General VP | Profile | |
David Terrell | BioTrack Officer | Profile | |
Jason Holden | Vice Development | Profile | |
Andrew Douglas | Chief Officer | Profile | |
Daniel Barton | CEO Director | Profile | |
Rebecca Adams | Vice Resources | Profile | |
Michael Vesey | Chief Officer | Profile |